Metraipolis › archive › dc_af520545c593

FLASH radiotherapy as an emerging paradigm in radioimmunotherapy: biological rationale, preclinical evidence, and translational roadmap — Europe PMC PMID:42662452

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42662452
DOI
10.3389/fimmu.2026.1869222
License (as archived)
solo-consultazione
Archived
2026-10-17T04:14:24.081Z
SHA-256 of the archived text
5746c79216932ee9c247ac2027586c39c0ed6b2778b5ca76591746e8ed153730
Stable URL of this page
https://metraipolis.com/documento/dc_af520545c593

How to cite

FLASH radiotherapy as an emerging paradigm in radioimmunotherapy: biological rationale, preclinical evidence, and translational roadmap — Europe PMC PMID:42662452 — Europe PMC (en), https://europepmc.org/article/MED/42662452 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_af520545c593 (Metraipolis archive dc_af520545c593, sha256 5746c79216932ee9c247ac2027586c39c0ed6b2778b5ca76591746e8ed153730)
BibTeX
@misc{dcaf520545c593,
  title = {FLASH radiotherapy as an emerging paradigm in radioimmunotherapy: biological rationale, preclinical evidence, and translational roadmap — Europe PMC PMID:42662452},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42662452},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_af520545c593; sha256 5746c79216932ee9c247ac2027586c39c0ed6b2778b5ca76591746e8ed153730},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42662452. Agents can read the archived copy with the MCP tool read_document.